Next- Generation Genetic Matching utilizing Hybrid Capture Technology.

Next-Generation Genetic Matching Utilizing Hybrid Capture Technology

A new single tube methodology for library preparation that streamlines laboratory workflow and enables full capture of HLA genes, with the opportunity for expandable content targeting additional transplant related genes.


Key Features

  • Early indexing enables a single tube workflow
  • Bead based normalization – No manual adjustment of [DNA]
  • Full HLA genes and additional transplant associated genes are captured using probes  
  • New gene content can be added without affecting the single tube workflow 
  • Compatible with the Illumina platforms; MiSeq, MiniSeq and iSeq
  • One Platform: The AlloSeq suite of solutions brings powerful pre-transplant testing and post-transplant surveillance to the Illumina sequencing platform

*AlloSeq Tx are available as CE/IVD and Research Use Only. For local regulatory status, please contact CareDx. Research Use Only products are not to be used for diagnostic procedures. AlloSeq is a trademark or registered trademark of CareDx Inc. or its subsidiaries in the US or other countries. AlloSeq is a registered trademark with the US Patent and Trademark Office.